Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Gutmann

Showing results (61-70 of 434) with videos related to

Pageof 44
Sort By:
Trends in Molecular Medicine|October 11, 2019
Microglia as Dynamic Cellular Mediators of Brain FunctionElizabeth C Wright-Jin, David H Gutmann
Trends in Neurosciences|January 15, 2013
Modeling cognitive dysfunction in neurofibromatosis-1Kelly A Diggs-Andrews, David H Gutmann
Neuro-Oncology Advances|July 10, 2020
Brain tumors in Neurofibromatosis type 1Amanda De Andrade Costa, David H Gutmann
Journal of Neuro-Oncology|January 28, 2005
Molecular pathogenesis of meningiomasArie Perry, David H Gutmann, Guido Reifenberger
Human Molecular Genetics|October 22, 2010
Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic miceLijun Wang, David H Gutmann, Raymond P Roos
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 3, 2003
The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytesBiplab Dasgupta, Laura L Dugan, David H Gutmann
Journal of Neuropathology and Experimental Neurology|June 14, 2011
Comparative characterization of the human and mouse third ventricle germinal zonesSonika Dahiya, Da Yong Lee, David H Gutmann
Oncogene|April 30, 2004
Disruption of 14-3-3 binding does not impair Protein 4.1B growth suppressionVictoria A Robb, Wen Li, David H Gutmann
Experimental Neurology|April 11, 2017
Human stem cell modeling in neurofibromatosis type 1 (NF1)Michelle L Wegscheid, Corina Anastasaki, David H Gutmann
Neurology. Genetics|August 2, 2018
Independent <i>NF1</i> mutations underlie café-au-lait macule development in a woman with segmental NF1Morgan E Freret, Corina Anastasaki, David H Gutmann
Pageof 44

Showing results (61-70 of 434) with videos related to

Sort By:
Pageof 44
Trends in Molecular Medicine|October 11, 2019
Microglia as Dynamic Cellular Mediators of Brain FunctionElizabeth C Wright-Jin, David H Gutmann
Trends in Neurosciences|January 15, 2013
Modeling cognitive dysfunction in neurofibromatosis-1Kelly A Diggs-Andrews, David H Gutmann
Neuro-Oncology Advances|July 10, 2020
Brain tumors in Neurofibromatosis type 1Amanda De Andrade Costa, David H Gutmann
Journal of Neuro-Oncology|January 28, 2005
Molecular pathogenesis of meningiomasArie Perry, David H Gutmann, Guido Reifenberger
Human Molecular Genetics|October 22, 2010
Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic miceLijun Wang, David H Gutmann, Raymond P Roos
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 3, 2003
The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytesBiplab Dasgupta, Laura L Dugan, David H Gutmann
Journal of Neuropathology and Experimental Neurology|June 14, 2011
Comparative characterization of the human and mouse third ventricle germinal zonesSonika Dahiya, Da Yong Lee, David H Gutmann
Oncogene|April 30, 2004
Disruption of 14-3-3 binding does not impair Protein 4.1B growth suppressionVictoria A Robb, Wen Li, David H Gutmann
Experimental Neurology|April 11, 2017
Human stem cell modeling in neurofibromatosis type 1 (NF1)Michelle L Wegscheid, Corina Anastasaki, David H Gutmann
Neurology. Genetics|August 2, 2018
Independent <i>NF1</i> mutations underlie café-au-lait macule development in a woman with segmental NF1Morgan E Freret, Corina Anastasaki, David H Gutmann
Pageof 44